Research Practice Clause Samples
The Research Practice clause defines the standards and procedures that must be followed when conducting research under the agreement. It typically outlines requirements such as adherence to ethical guidelines, compliance with applicable laws and institutional policies, and proper documentation of research activities. For example, it may require that all experiments involving human subjects receive prior approval from an ethics committee or that data is managed according to specific confidentiality protocols. The core function of this clause is to ensure that all research is conducted responsibly and legally, thereby protecting both parties from legal or ethical violations and maintaining the integrity of the research process.
Research Practice. 3.1 The Institution and the Grantholder will at all times during the continuance of the Agreement comply with:
3.1.1 the Policies;
3.1.2 the terms of the Agreement; and
3.1.3 any laws and regulations (as amended from time to time) applicable to the Project and the Agreement including human tissue legislation, health & safety legislation, the Data Protection Legislation and the Bribery Act 2010.
3.2 It is a condition of the Grant that the research undertaken in connection with the Project is conducted in accordance with best scientific and ethical practice. The Institution warrants that it has in place, and will continue to have in place through the Grant Period, formal written policies setting out the standards to be met in the conduct of research and the procedures to be followed following any allegation of research misconduct.
3.3 If at any time during or after the Grant Period, allegations of research misconduct are made in relation to the Project, or in relation to the Grantholder (or any other person involved in the Project) in connection with any other research, and are, in the reasonable opinion of Diabetes UK, substantiated, Diabetes UK reserves the right to take such steps as it, at its absolute discretion, considers appropriate which may include (but is not limited to):
3.3.1 Requiring the Institution to remove the Grantholder (or any other person involved in the Project) from the Project;
3.3.2 Requiring the Institution and/or Grantholder to retract published material;
3.3.3 withholding payment of subsequent instalments of the Grant, or requiring the Institution to reimburse Diabetes UK for some or all instalments of the Grant already paid;
3.3.4 taking such steps as it considers necessary to monitor the subsequent conduct of the Project and the Institution and the Grantholder will co-operate with Diabetes UK to facilitate this;
3.3.5 terminating the Grant with immediate effect.
3.4 The Institution and the Grantholder will conduct the Project in accordance with the principles set out in the Concordat to Support Research Integrity policy (▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇.▇▇/highereducation/Documents/2012/TheConcordatToSup portResearchIntegrity.pdf)
3.5 Prior to the commencement of the Project, the Grantholder and the Institution will obtain any and all licences, consents and approvals (including ethical approval) necessary to the conduct of the Project, will continue to hold such licences, consents and approvals during the Grant Period, and will prom...
Research Practice. The ▇▇▇▇▇ ▇▇▇▇▇▇ must ensure that research under the Project is conducted in compliance with all applicable laws and regulations and that all necessary licences and approvals have been obtained.
Research Practice. The Employing Institution must ensure that all the necessary legal and regulatory requirements in order to conduct the research are met and all the necessary licences and Ethical Committee approvals have been obtained. Where any part of the research is to be conducted outside the UK such legal and regulatory requirements, and such licences and approvals, should include those applicable in the additional countries involved. The Employing Institution must have in place formal written procedures for the handling of allegations of research misconduct and on request must make those available to Guts UK. The ▇▇▇▇▇ ▇▇▇▇▇▇ or any other person working on the Grant Activities must carry out any animal research using the Grant in accordance with the appropriate Home Office licences and certificates which must remain valid. The Employing Institution must ensure that research involving animals gives due consideration to the refinement, reduction and replacement of animals in research and adheres to the principles in the NC3Rs “Responsibility in the Use of Animals in Bioscience Research”. Site visits may be made at any time subject to mutual agreement. Payment of the Grant will not commence until the Grant Budget, including salary details if covered and a breakdown of consumable and other miscellaneous costs, has been confirmed by the Employing Institution's Administrative Officer in the Admin Officer Letter. Guts UK will not cover any expenditure not stated in the Grant Budget. Conference travel expenses and publication costs will only be covered if allowed by the grant application guidelines published by Guts UK for the type of the project funded by the Grant. The Grant Budget in the Admin Officer Letter cannot include any items of expenditure which are disallowed in the grant application guidelines published by Guts UK for the type of project funded by the Grant. ▇▇▇▇▇ instalments are paid to the Employing Institution quarterly, in arrears, subject to receipt by Guts UK of an invoice. Quarterly invoices must state the start and end dates of the period covered by the invoice and provide a breakdown of costs incurred against the items of expenditure in the Grant Budget. All invoices must be submitted within 6 months of the end of the Grant Period. Guts UK will not pay the final claim until it has received the Final Report (see term 6.2) and is satisfied that the Grant Activities have been delivered in accordance with the Award Letter and any Special Conditions. Guts UK...
Research Practice. 3.1. The Lead Applicant Institution and Lead Applicant shall ensure the Research;
3.1.1. is primarily relevant to the BactiVac Network and is compliant with ODA rules and regulations as set out by the OECD (guidance can be found at ▇▇▇▇▇://▇▇▇.▇▇▇▇.▇▇▇/files/legacy/international/gcrfodaguidance-pdf/); or
3.1.2. is primarily relevant to the BactiVac Network and demonstrates strong industry engagement; or
3.1.3. is primarily relevant to the BactiVac Network and is aligned to UK Health.
3.2. Prior to the commencement of the Research, the Lead Applicant and the Lead Applicant Institution will obtain any and all licences, consents and approvals (including ethical approval) necessary for the conduct of the Research and will continue to hold such licences, consents and approvals during the Duration.
3.3. Where any part of the Research is to be conducted outside the UK such legal and regulatory requirements, and such licences and approvals should include those applicable in the additional countries involved.
3.4. The Lead Applicant Institution must ensure that the requirements under the UK Policy Framework for Health and Social Care Research (or equivalent) are met for managing, monitoring and for research involving NHS patients, their organs, tissues or data and the necessary arrangement are in place with partner organisations. Where it also accepts the responsibilities of a Sponsor, (as defined in the UK Policy Framework for Health and Social Care Research), it must also ensure that the requirements of Sponsors are met.
3.5. The Lead Applicant Institution shall be responsible for managing and monitoring statutory requirements for which it accepts responsibility, for example, in relation to legislation of clinical trials, use of human organs, tissues and data.
3.6. For clinical studies involving human participants and/or patients, appropriate consent must be obtained. When collaborating with other laboratories, or where animal facilities are provided by third parties, researchers and the local ethics committee in the UK should satisfy themselves that welfare standards consistent with the principles of UK legislation (e.g. the Animals (Scientific Procedures) Act 1986) and set out in the guidance document 'Responsibility in the use of animals in bioscience research' (available at ▇▇▇.▇▇▇▇▇.▇▇▇.▇▇/▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇-▇▇▇▇▇▇▇-▇▇▇▇▇▇▇▇▇▇-▇▇▇▇▇▇▇▇) are applied and maintained.
3.7. The Lead Applicant Institution is expected, wherever possible, to adopt procedures and tech...
Research Practice. 3.1. The Lead Applicant Institution and Lead Applicant shall ensure the Research;
3.1.1. is primarily for the benefit of Official Development Assistance (ODA) eligible countries as outlined in the Organisation for Economic Co-operation and Development (OECD) Development Co-Operation Directorate list (▇▇▇▇▇://▇▇▇.▇▇▇▇.▇▇.▇▇/documents/g3-nihr-oda-guidance-for- researchers/24953). ODA eligibility of the Research will be approved upon review of the Application Form.
3.1.2. is primarily relevant to the FAILSAFE PROJECT and GAMRIF and is compliant with ODA rules and regulations as set out by the OECD (▇▇▇▇▇://▇▇▇.▇▇▇▇.▇▇.▇▇/documents/g3-nihr-oda-guidance-for- researchers/24953);
3.1.3. is primarily relevant to the FAILSAFE PROJECT and demonstrates strong industry engagement.
3.2. The Lead Applicant and Lead Applicant Institution shall ensure the Grant is used solely for the delivery of the Research and must not, without the prior written consent of UoE make any material changes to the Research.
3.3. Prior to the commencement of the Research, the Lead Applicant and the Lead Applicant Institution will obtain any and all licences, consents and approvals (including ethical approval) necessary for the conduct of the Research and will continue to hold such licences, consents and approvals during the Duration.
3.4. The Grant must not be used to support activity which influences or attempts to influence Parliament, Government or political parties, to propagate a religion or belief, or to influence the awarding or renewal of contracts of grants, or to influence legislative or regulatory action.
3.5. The Lead Applicant must provide prior notification to UoE of any contact they may make directly with missions and or representatives of governments in relation to the promotion of the agreed objectives under this Grant through agreed meetings and reports.
3.6. Where, before or during the Duration, the Lead Applicant and the Lead Applicant Institution receives any funding from any other source or person towards the Research that was not already committed to the Lead Applicant Institution and disclosed to UoE, UoE may, where that funding duplicates funding of the Grant, require repayment of the Grant (up to the amount of duplicate funding received).
3.7. The Lead Applicant and the Lead Applicant Institution agrees and accepts that it will not apply for duplicate funding in respect of any part of the Grant for the Research or any related administration costs that UoE has provide...
Research Practice. The Institution and the Grantholder will at all times during the continuance of this Agreement comply with: the Policies; the terms of this Agreement; and any laws and regulations (as amended from time to time) applicable to the Project and this Agreement including human tissue legislation, health & safety legislation, the Data Protection Act 1998 and the Bribery Act 2010. It is a condition of the Grant that the research undertaken in connection with the Project is conducted in accordance with best scientific and ethical practice. The Institution warrants that it has in place, and will continue to have in place through the Grant Period, formal written policies setting out the standards to be met in the conduct of research and the procedures to be followed following any allegation of research misconduct. If at any time during or after the Grant Period, allegations of research misconduct are made in relation to the Grant, or in relation to the Grantholder in connection with any other research, and are, in the reasonable opinion of Diabetes UK, substantiated, Diabetes UK reserves the right to take such steps as it, at its absolute discretion, considers appropriate which may include (but is not limited to): Requiring the Institution to remove the Grantholder from the Project; Requiring the Institution and/or Grantholder to retract published material; withholding payment of subsequent instalments of the Grant, or requiring the Institution to reimburse Diabetes UK for some or all instalments of the Grant already paid; taking such steps as it considers necessary to monitor the subsequent conduct of the Project and the Institution and the Grantholder will co-operate with Diabetes UK to facilitate this; terminating the Grant with immediate effect. The Institution and the Grantholder will conduct the Project in accordance with the principles set out in the Concordat to Support Research Integrity policy (▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇.▇▇/highereducation/Documents/2012/TheConcordatToSupportResearchIntegrity.pdf) The Grantholder and the Institution will comply with the terms of the policy on the use of animals in medical research (insert link to policy). Prior to the commencement of the Project, the Grantholder and the Institution will obtain any and all licences, consents and approvals (including ethical approval) necessary to the conduct of the Project, will continue to hold such licences, consents and approvals during the Grant Period, and will promptly upon request p...